Explore 2 treatment options for hemophilia A. View online
Important Safety Information | Prescribing Information
Esperoct antihemophilic factor (recombinant), glycopegylated-exei logo.
Esperoct® is used to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. See full indication below
 
Important Safety Information | Prescribing Information
Novoeight Antihemophilic Factor (Recombinant) logo.
Novoeight® is used to control and prevent bleeding in people with hemophilia A. See full indication below.
For women, girls, and people assigned female at birth with hemophilia A
 
When you’re on the go, choose FleXXibility factors on your termsa
aPrior to reconstitution, Esperoct® and Novoeight® can be stored from 36 °F to 46 °F for up to 30 months, at room temperature up to 86 °F for up to 12 months, or up to 104 °F for up to 3 months. See Prescribing Information for complete product storage information.
Discover 2 hemophilia A treatment options designed around your lifestyle
Logo for Esperoct® antihemophilic factor (recombinant), glycopegylated-exei alongside a pink purse filled with an Esperoct® vial and other lifestyle items, including cell phone, lipstick, car keys, perfume, and house. A patient quote reads: ‘I really like the fact that Esperoct® is stable at room temperature up to 104 degrees F. I can just throw it in my bag and go and then if I need to stop and infuse, I can do that.’ Text under the quote reads: ‘Tammy, a woman living with hemophilia A who uses Esperoct®’
Logo for Novoeight® Antihemophilic Factor (Recombinant) alongside a striped pink purse filled with a Novoeight® vial and various beach items, including sandals, sunscreen, sunglasses, beach chair, and umbrella. A patient quote reads: ‘I have a good experience with Novoeight®. Anytime that I’ve had a bleed, I’ve administered Novoeight® and it does its job for me.’ Text under the quote reads: ‘Elise, a woman living with hemophilia A who uses Novoeight®’
Learn more about these treatment options for life on the go:
Explore Esperoct®   Get to know Novoeight®
 
Keep scrolling to learn more
 
Esperoct® Selected Important Safety Information
Who should not use Esperoct®?
  • You should not use Esperoct® if you are allergic to factor VIII or any of the other ingredients of Esperoct® or if you are allergic to hamster proteins
What is the most important information I need to know about Esperoct®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center
  • Call your healthcare provider right away or get emergency treatment right away if you get any signs of an allergic reaction, such as: hives, chest tightness, wheezing, dizziness, difficulty breathing, and/or swelling of the face
Novoeight® Selected Important Safety Information
Who should not use Novoeight®?
  • You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins
What is the most important information I need to know about Novoeight®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia center
  • Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands
 
Does it ever seem like you’re not being heard by your doctor? You deserve a diagnosis and treatment options for your hemophilia A.
Numerical graphic that reads ‘42%’
  According to a healthcare provider survey, 42% (N=29) felt women with inherited bleeding disorders, including symptomatic carriers, experience less access to care as compared to men. Numerical graphic that reads ‘42%’
Many women feel that their doctors dismiss or minimize their bleeding symptoms. But your needs as a woman are important. That’s why we’ve built resources to help you talk to your doctor and explore treatment options.
Use our tools to track your symptoms and ask your doctor about getting the bleed protection you deserve with Esperoct® or Novoeight®.
 Be Empowered 
 
  Photo of two RBCLs, Noberto and Lorie, standing side by side
Your Rare Blood Community Liaison (RBCL) is here to help.
Life with a bleeding disorder can bring challenges. Our RBCLs are experienced and ready to provide you with one-on-one support, including:
Information about Esperoct® and Novoeight®
Bleeding disorder & lifestyle education
Updates on local events
Tools to help you manage your bleeding disorder
 Reach out to your RBCL 
 
What is Esperoct®?
Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] is an injectable medicine to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. Your healthcare provider may give you Esperoct® when you have surgery
  • Esperoct® is not used to treat von Willebrand Disease
Important Safety Information
Who should not use Esperoct®?
  • You should not use Esperoct® if you are allergic to factor VIII or any of the other ingredients of Esperoct® or if you are allergic to hamster proteins
What is the most important information I need to know about Esperoct®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center
  • Call your healthcare provider right away or get emergency treatment right away if you get any signs of an allergic reaction, such as: hives, chest tightness, wheezing, dizziness, difficulty breathing, and/or swelling of the face
What should I tell my healthcare provider before using Esperoct®?
  • Before taking Esperoct®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII
  • Your body can make antibodies called “inhibitors” against Esperoct®, which may stop Esperoct® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Esperoct®
What are the possible side effects of Esperoct®?
  • Common side effects of Esperoct® include rash or itching, and swelling, pain, rash or redness at the location of infusion
Please click here for Prescribing Information.
Esperoct® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
What is Novoeight®?
Novoeight® (antihemophilic factor, recombinant) is an injectable medicine used to control and prevent bleeding in people with hemophilia A. Your healthcare provider may give you Novoeight when you have surgery
  • Novoeight® is not used to treat von Willebrand Disease
Important Safety Information
Who should not use Novoeight®?
  • You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins
What is the most important information I need to know about Novoeight®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia center
  • Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands
What should I tell my healthcare provider before using Novoeight®?
  • Before taking Novoeight®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII
  • Your body can make antibodies called “inhibitors” against Novoeight®, which may stop Novoeight® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Novoeight®
What are the possible side effects of Novoeight®?
  • Common side effects of Novoeight® include inhibitors in patients who were not previously treated with factor VIII products, swelling or itching at the location of injection, and fever
Please click here for Prescribing Information.
Novoeight® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
 
PLEASE DO NOT RESPOND TO THIS EMAIL. If you would like to contact us, please click here or call 1‑877‑744‑2579.
Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
Esperoct® and Novoeight® are registered trademarks of Novo Nordisk Health Care AG.
All other trademarks, registered or unregistered, are the property of their respective owners.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2025 Novo Nordisk  All rights reserved.  US24ESP00100  March 2025
Novo Nordisk logo.
Novo Nordisk logo.